Tourmaline Bio, Inc. Quarterly Assets in USD from Q4 2020 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: Tourmaline Bio, Inc. quarterly Assets history and growth rate from Q4 2020 to Q3 2024.
Tourmaline Bio, Inc. Assets for the quarter ending September 30, 2024 was $328M, a 117% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$328M	+$177M	+117%	Sep 30, 2024	10-Q	2024-11-07
Q2 2024	$345M	+$186M	+117%	Jun 30, 2024	10-Q	2024-08-08
Q1 2024	$359M	+$187M	+108%	Mar 31, 2024	10-Q	2024-05-13
Q4 2023	$210M	+$201M	+2211%	Dec 31, 2023	10-Q	2024-11-07
Q3 2023	$151M	-$55.5M	-26.9%	Sep 30, 2023	10-Q	2023-11-14
Q2 2023	$159M	-$61.8M	-28%	Jun 30, 2023	10-Q	2023-08-14
Q1 2023	$173M	-$64.6M	-27.2%	Mar 31, 2023	10-Q	2023-05-15
Q4 2022	$9.1M	-$242M	-96.4%	Dec 31, 2022	10-K	2024-03-19
Q3 2022	$207M	-$54.8M	-21%	Sep 30, 2022	10-Q	2022-11-10
Q2 2022	$221M	-$51.9M	-19%	Jun 30, 2022	10-Q	2022-08-15
Q1 2022	$237M	+$92.3M	+63.7%	Mar 31, 2022	10-Q	2022-05-12
Q4 2021	$251M	+$98.6M	+64.6%	Dec 31, 2021	10-K	2023-03-31
Q3 2021	$261M			Sep 30, 2021	10-Q	2021-11-12
Q2 2021	$273M			Jun 30, 2021	10-Q	2021-08-12
Q1 2021	$145M			Mar 31, 2021	10-Q	2021-06-14
Q4 2020	$153M			Dec 31, 2020	10-K	2022-03-17

* An asterisk sign (*) next to the value indicates that the value is likely invalid.